[Studies on anti-inflammatory agents. 3. Effect of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (Y-3642) on pyretic reaction, vascular permeability and granuloma formation in experimental animals].
D000315:Adrenalectomy; D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects*; D004487:Edema / Q000188:drug therapy; D005334:Fever / Q000188:drug therapy*; D006099:Granuloma / Q000188:drug therapy*; D006168:Guinea Pigs; D006854:Hydrocortisone / Q000494:pharmacology; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D010538:Peritonitis / Q000188:drug therapy; D010653:Phenylbutazone / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D014945:Wound Healing / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D011725:Pyridines; D012459:Salicylates; D000632:Aminopyrine; D009020:Morphine; D010653:Phenylbutazone; D006854:Hydrocortisone